MOONLAKE IMMUNOTHERAPEUTICS Class A Ordinary Shares (par value $0.0001 per share) SALES AGREEMENTSales Agreement • August 31st, 2023 • MoonLake Immunotherapeutics • Pharmaceutical preparations • New York
Contract Type FiledAugust 31st, 2023 Company Industry JurisdictionMoonLake Immunotherapeutics, a Cayman Islands exempted company (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows: